Today: 9 June 2026
Rocket Lab stock rebounds, holds after-hours bid as RKLB traders weigh insider sales and earnings clock

Rocket Lab stock rebounds, holds after-hours bid as RKLB traders weigh insider sales and earnings clock

NEW YORK, Jan 9, 2026, 17:36 EST — After-hours

  • Rocket Lab shares rose about 2.1% in regular trading and edged up in extended trade
  • SEC filings this week showed the CFO and COO sold stock under pre-set trading plans
  • Next focal point is fourth-quarter results, expected late February by several calendars

Rocket Lab Corp shares closed up 2.1% on Friday and were modestly higher in after-hours trading, as the space launch and satellite builder steadied after a choppy run. The stock ended the session at $84.85 and was around $85.12 in extended trade.

The move matters because Rocket Lab’s rally has pulled more short-term money into the name, and the tape has started reacting to filings and calendar risk rather than new contracts. Rocket Lab stock is up about 200% over the past 12 months, Barron’s reported this week, putting execution and timing back in focus.

That scrutiny sharpened after insider disclosures. Chief Financial Officer Adam Spice exercised options and sold about 1.37 million shares on Jan. 5 under a Rule 10b5-1 plan — a pre-arranged trading program that lets insiders buy or sell stock on a set schedule — while Chief Operating Officer Frank Klein sold 100,000 shares on Jan. 2 under a similar plan, SEC filings showed.

The bigger swing factor remains defense work. Rocket Lab said in December it won an $816 million Space Development Agency prime contract to build 18 missile-warning and tracking satellites, with options that could lift the award. “Rocket Lab is honored to play a role in enabling this,” founder and CEO Peter Beck said in the release. GlobeNewswire

The SDA Tranche-3 procurement totals about $3.5 billion across four firms — Rocket Lab, Lockheed Martin, Northrop Grumman and L3Harris — under fixed-price awards, Reuters reported at the time.

Investors now want to see that backlog turn into revenue without slipping schedules. In its November results update, Rocket Lab forecast fourth-quarter revenue of $170 million to $180 million and GAAP gross margin — profit after direct costs, under standard U.S. accounting rules — of 37% to 39%; it also said Neutron, its larger reusable rocket, should arrive at its Launch Complex 3 in the first quarter of 2026, with the first launch after qualification testing.

But the trade has a bad habit of punishing delays. Any stumble in launch cadence, a setback in Neutron qualification, or slower conversion of government orders into billed revenue could hit sentiment fast, especially with insiders selling stock on auto-pilot plans.

Rocket Lab has not announced a date for its fourth-quarter results, but several earnings calendars peg the report around Feb. 26. Traders will be listening for a clean read-through on margins, cash use and whether Neutron’s first launch is still tracking as the next milestone.

Stock Market Today

  • SailPoint Q1 Earnings Beat Estimates Amid Revenue Growth
    June 9, 2026, 10:14 AM EDT. SailPoint, Inc. (SAIL) reported Q1 earnings of $0.05 per share, surpassing the Zacks Consensus Estimate of $0.04 by 17.65%. Revenue increased to $280.14 million, beating estimates by 1.41% and up from $230.47 million a year ago. Despite earnings surprises and revenue growth, SailPoint shares have declined 12.6% year-to-date against the S&P 500's 8.2% rise. The company holds a Zacks Rank #3 (Hold), indicating expected market-aligned performance. Consensus estimates forecast Q2 EPS of $0.08 on $310.79 million revenue and fiscal year EPS of $0.32 on $1.27 billion revenue. Industry trends in the Zacks Internet-Software sector will influence future stock performance. Investors await management's commentary for guidance on sustainability.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Previous Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next
Next Story

Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next

Go toTop